SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.50-2.7%Nov 7 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (16652)3/6/1998 9:00:00 PM
From: Pseudo Biologist  Read Replies (1) of 32384
 
WTD, take a look at this post:

Message 3626404

and those "around it."

Bottom line GM-CSF is a protein drug sold by Immunex for decent profits. The closely related one, G-CSF aka Neupogen, is sold by Amgen for obscene profits. EPO aka Epogen is also sold by Amgen (and J&J), and is not too far fetched, conceptually, to think that if one can make a small molecule version of GM-CSF, one could do the same for EPO. Henry could explain (has explained?) in more detail; something to do with STATs.

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News